Amy Feehan

Amy Feehan

Boehringer Ingelheim - / United States
Medical and Health Sciences / Health Sciences
AD Scientific Index ID: 4888843
person_outline Amy Feehan's MOST POPULAR ARTICLES
1-) Racial and ethnic disparities in receipt of medications for treatment of COVID-19—United States, March 2020–August 2021JL Wiltz, AK Feehan, NAM Molinari, CN Ladva, BI Truman, J Hall, ...Morbidity and Mortality Weekly Report 71 (3), 96, 2022452022
2-) Emergence of an early SARS-CoV-2 epidemic in the United StatesM Zeller, K Gangavarapu, C Anderson, AR Smither, JA Vanchiere, ...Cell 184 (19), 4939-4952. e15, 2021452021
3-) Novel endomorphin analogs are more potent and longer-lasting analgesics in neuropathic, inflammatory, postoperative, and visceral pain relative to morphineAK Feehan, J Morgenweck, X Zhang, AT Amgott-Kwan, JE ZadinaThe Journal of Pain 18 (12), 1526-1541, 2017442017
4-) Racial and workplace disparities in seroprevalence of SARS-CoV-2, Baton Rouge, Louisiana, USAAK Feehan, C Velasco, D Fort, JH Burton, EG Price-Haywood, ...Emerging infectious diseases 27 (1), 314, 2021432021
5-) Morphine immunomodulation prolongs inflammatory and postoperative pain while the novel analgesic ZH853 accelerates recovery and protects against latent sensitizationAK Feehan, JE ZadinaJournal of neuroinflammation 16, 1-20, 2019432019